GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Company

X4 Pharmaceuticals, Inc

Filed

December 20, 2022

Accession Number

0001072613-22-000662